- $466.48m
- $431.92m
- $139.88m
- 82
- 32
- 89
- 75
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 2.34 | ||
Price to Tang. Book | 6.16 | ||
Price to Free Cashflow | 60.48 | ||
Price to Sales | 3.08 | ||
EV to EBITDA | 166.51 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -4.56% | ||
Return on Equity | -7.02% | ||
Operating Margin | -6.52% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 56.34 | 68.8 | 90.29 | 127.12 | 139.88 | 151.85 | 167.15 | 25.53% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Innovid Corp. provides an enterprise software platform for the creation, delivery, measurement, and optimization of advertising across connected television (TV) (CTV), linear TV, mobile, and desktop environments. The Company’s cloud-based enterprise technology platform is purpose-built for CTV, with a comprehensive view of the full advertising ecosystem, including linear TV, mobile, and desktop channels. Its integrated platform consists of three core solutions: Ad Serving, Creative Personalization, and Measurement Solutions. Its open platforms enable its clients to seamlessly activate partners such as DoubleVerify, Integral Ad Science, Oracle Data Cloud, among many others. Its Measurement Solution, Innovid XP, is designed to provide holistic and granular household-level analysis for the TV and digital ecosystem. It counts many of the brand advertisers as customers, including Anheuser-Busch InBev, CVS Pharmacy, Kellogg’s, Mercedes-Benz, Target, Sanofi, and more.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- September 30th, 2024
- Incorporated
- November 29th, 2021
- Public Since
- April 5th, 2021
- No. of Shareholders
- 111
- No. of Employees
- 466
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
New York Stock Exchange
- Shares in Issue
- 148,561,159

- Address
- 116 East 16Th Street, 6Th Floor, NEW YORK, 10003
- Web
- https://investors.innovid.com/
- Phone
- +1 2129667555
- Contact
- Lauren Hartman
- Auditors
- Kost, Forer, Gabbay & Kasierer
Upcoming Events for CTV
Innovid Corp Annual Shareholders Meeting
Similar to CTV
A10 Networks
New York Stock Exchange
Accenture
New York Stock Exchange
Alibaba Holding
New York Stock Exchange
Alight
New York Stock Exchange
Allurion Technologies
New York Stock Exchange
FAQ
As of Today at 20:19 UTC, shares in Innovid are trading at $3.14. This share price information is delayed by 15 minutes.
Shares in Innovid last closed at $3.14 and the price had moved by +103.9% over the past 365 days. In terms of relative price strength the Innovid share price has outperformed the S&P500 Index by +70.08% over the past year.
The overall consensus recommendation for Innovid is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreInnovid does not currently pay a dividend.
Innovid does not currently pay a dividend.
Innovid does not currently pay a dividend.
To buy shares in Innovid you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $3.14, shares in Innovid had a market capitalisation of $466.48m.
Here are the trading details for Innovid:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: CTV
Based on an overall assessment of its quality, value and momentum Innovid is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Innovid is $3.15. That is 0.32% above the last closing price of $3.14.
Analysts covering Innovid currently have a consensus Earnings Per Share (EPS) forecast of -$0.08 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Innovid. Over the past six months, its share price has outperformed the S&P500 Index by +71.9%.
As of the last closing price of $3.14, shares in Innovid were trading +42.08% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Innovid PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $3.14.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Innovid's directors